The quarantine authorities are investigating whether a’breakthrough infection’ related to a nursing care provider in Suncheon, Jeollanam-do, which was confirmed after receiving a new coronavirus infection (Corona 19) vaccine, was confirmed.
The Central Defense Countermeasure Headquarters (Bang Dae-bon) made this announcement in reference to a reporter’s inquiry on the 29th. On this day, in Suncheon City, there was a case in which a caregiver A, who received two doses of AstraZeneca (AZ) vaccine, was confirmed to be corona 19. On the 28th, the nursing care provider said that he had a diagnostic test after showing suspected symptoms of Corona 19.
Breakthrough infection is a case of infection after 14 days, the period in which antibodies are formed, after receiving the Corona 19 vaccine at the specified number of vaccination intervals. A’s second vaccination date was the last 18 days, and as it was confirmed 11 days after vaccination, it was not determined whether it would be a breakthrough infection. “We are currently investigating,” said Bang Dae-bon, and said, “If it is a breakthrough infection, we have to investigate on a case-by-case basis and then evaluate it based on the results.”
As of the 21st, 4 cases of breakthrough infection were confirmed in Korea. This is 0.0003% of the 1.84 million people who completed the vaccination at the time. The quarantine authorities plan to disclose the infection route and the possibility of further transmission of the breakthrough infection once a week.
Meanwhile, the quarantine authorities decided to look at the vaccination policy trends of other European countries regarding the recommendation of the European Medicines Agency (EMA) to vaccinate Pfizer’s corona19 vaccine even for adolescents aged 12 to 15 years old. The Corona 19 Vaccination Response Promotion Team (Promotion Team) said, “We are collecting scientific evidence related to EMA recommendations,” and “We plan to monitor the vaccination policy trends of European countries in accordance with the EMA recommendations.”
At an extraordinary meeting held on the 28th (local time), the EMA recommended approving a plan to increase the vaccination age so that the Pfizer vaccine can be vaccinated to ages 12-15. Currently, in the EU, only those over 16 years of age are vaccinated with Pfizer vaccine, but if approved by the European Commission, EU countries will decide whether or not to receive the Pfizer vaccine for 12-15 years old.
In the United States and Canada, Pfizer vaccines are already available for ages 12 to 15 years old. The promotion team will collect data from each country and provide advice on vaccine experts based on the collected information.
Reporter Lee Tae-yoon [email protected]